These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 25701034

  • 1. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery.
    Yang Y, Yang Y, Xie X, Wang Z, Gong W, Zhang H, Li Y, Yu F, Li Z, Mei X.
    Biomaterials; 2015 Apr; 48():84-96. PubMed ID: 25701034
    [Abstract] [Full Text] [Related]

  • 2. Photolabile-caged peptide-conjugated liposomes for siRNA delivery.
    Xie X, Yang Y, Yang Y, Mei X.
    J Drug Target; 2015 Apr; 23(9):789-99. PubMed ID: 25675844
    [Abstract] [Full Text] [Related]

  • 3. A photo-responsive peptide- and asparagine-glycine-arginine (NGR) peptide-mediated liposomal delivery system.
    Xie X, Yang Y, Yang Y, Zhang H, Li Y, Mei X.
    Drug Deliv; 2016 Sep; 23(7):2445-2456. PubMed ID: 25693640
    [Abstract] [Full Text] [Related]

  • 4. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.
    Lin W, Xie X, Yang Y, Liu H, Fu X, Chen Y, Liu H, Yang Y.
    J Pharm Pharmacol; 2015 Sep; 67(9):1215-31. PubMed ID: 25880614
    [Abstract] [Full Text] [Related]

  • 5. A near-infrared two-photon-sensitive peptide-mediated liposomal delivery system.
    Yang Y, Yang Y, Xie X, Cai X, Wang Z, Gong W, Zhang H, Li Y, Mei X.
    Colloids Surf B Biointerfaces; 2015 Apr 01; 128():427-438. PubMed ID: 25766920
    [Abstract] [Full Text] [Related]

  • 6. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y, Yang Y, Xie X, Cai X, Zhang H, Gong W, Wang Z, Mei X.
    Biomaterials; 2014 May 01; 35(14):4368-81. PubMed ID: 24565519
    [Abstract] [Full Text] [Related]

  • 7. Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery.
    Lin W, Xie X, Deng J, Liu H, Chen Y, Fu X, Liu H, Yang Y.
    J Drug Target; 2016 May 01; 24(2):134-46. PubMed ID: 26176270
    [Abstract] [Full Text] [Related]

  • 8. Dual stimulus of hyperthermia and intracellular redox environment triggered release of siRNA for tumor-specific therapy.
    Yang Y, Yang Y, Xie X, Xu X, Xia X, Wang H, Li L, Dong W, Ma P, Liu Y.
    Int J Pharm; 2016 Jun 15; 506(1-2):158-73. PubMed ID: 27106526
    [Abstract] [Full Text] [Related]

  • 9. Photo-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapy.
    Yang Y, Xie X, Yang Y, Zhang H, Mei X.
    J Pharm Sci; 2015 Apr 15; 104(4):1328-39. PubMed ID: 25630979
    [Abstract] [Full Text] [Related]

  • 10. Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy.
    Takara K, Hatakeyama H, Kibria G, Ohga N, Hida K, Harashima H.
    J Control Release; 2012 Aug 20; 162(1):225-32. PubMed ID: 22728515
    [Abstract] [Full Text] [Related]

  • 11. Efficient siRNA Delivery Using Novel Cell-Penetrating Peptide-siRNA Conjugate-Loaded Nanobubbles and Ultrasound.
    Xie X, Lin W, Li M, Yang Y, Deng J, Liu H, Chen Y, Fu X, Liu H, Yang Y.
    Ultrasound Med Biol; 2016 Jun 20; 42(6):1362-74. PubMed ID: 27012462
    [Abstract] [Full Text] [Related]

  • 12. Co-delivery of CPP decorated doxorubicin and CPP decorated siRNA by NGR-modified nanobubbles for improving anticancer therapy.
    Ma R, Nai J, Zhang J, Li Z, Xu F, Gao C.
    Pharm Dev Technol; 2021 Jul 20; 26(6):634-646. PubMed ID: 33843423
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
    Zhang Q, Tang J, Fu L, Ran R, Liu Y, Yuan M, He Q.
    Biomaterials; 2013 Oct 20; 34(32):7980-93. PubMed ID: 23891517
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake.
    Takara K, Hatakeyama H, Ohga N, Hida K, Harashima H.
    Int J Pharm; 2010 Aug 30; 396(1-2):143-8. PubMed ID: 20457236
    [Abstract] [Full Text] [Related]

  • 17. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.
    Kibria G, Hatakeyama H, Harashima H.
    Int J Pharm; 2011 Jun 30; 412(1-2):106-14. PubMed ID: 21414394
    [Abstract] [Full Text] [Related]

  • 18. Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy.
    Chen Y, Wu JJ, Huang L.
    Mol Ther; 2010 Apr 30; 18(4):828-34. PubMed ID: 20068551
    [Abstract] [Full Text] [Related]

  • 19. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
    Mei L, Fu L, Shi K, Zhang Q, Liu Y, Tang J, Gao H, Zhang Z, He Q.
    Int J Pharm; 2014 Jul 01; 468(1-2):26-38. PubMed ID: 24709209
    [Abstract] [Full Text] [Related]

  • 20. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
    Jiang T, Zhang Z, Zhang Y, Lv H, Zhou J, Li C, Hou L, Zhang Q.
    Biomaterials; 2012 Dec 01; 33(36):9246-58. PubMed ID: 23031530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.